Moreover, as occurred in many high-income countries in the past decade [ 8 , 27 ], also in our analysis the incidence of IMD showed a decreasing trend among all serogroups (from 0.58 to 0.28) over the last 6-year study period, even if fluctuations have been historically reported [ 10 , 66 ] suggesting that future incidence remains still uncertain.
← all excerpts
Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programme.
1
—
—